BETRFOTCPharmaceutical PreparationsFiscal year ends January 31
BetterLife Pharma Inc.
Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)
Close on Oct 19, 2026
- Market cap
- $22.36M
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Jan 31, 2026
BetterLife Pharma reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in BetterLife Pharma's annual report. Trading prices and yields need FINRA TRACE data.